Belotero - Dermal Fillers

This is a non-animal Hyaluronic Acid gel (NaHA) created by Anteis. Belotero is a new crosslinked hyaluronic acid, monophonic in composition. A product from Switzerland, it is mainly distributed by Merz Pharma UK limited and was launched in the U.K in early 2007. Originally, the product was designed from biofermentaion of hyaluronic acid, which is a substance that exists naturally in the body of human beings.

The manufacturers point out that the acid component makes the product totally compatible with the body and that it is fully biodegradable once used. The creation process involves using cohesive polydensified matrix (CPM), a technology that involves a unique process that is capable of giving the product remarkable elasticity. It is this elasticity that gives the product its monophonic nature. Compared to biphasic products, this product can yield better results in terms of volume increase and wrinkle reduction.

Belotero® has a unique, cohesive polydensified structure consisting of a highly cohesive gel. This gel is easily injected through small diameters during treatment. Normally, no allergy tests are required on the skin before the product can be used for treatment on a patient. The product is highly non-permanent since the hyaluronic acid is gradually broken down in the body. Over time, there is no trace of the filler left in the body and another injection will be necessary if the results were satisfactory and desired once more.

It comes in three product formulations which are basic, soft and intense. For volume enhancement treatments, Belotero basic is best. Belotero soft is suitable for superficial wrinkles. Belotero intense is ideal for lines and wrinkles and is injected deeply into the skin by use of a 27G needle. The formulations come in packages of 22.5, 20 and 25.5 mg/ml for basic, soft and intense respectively.

The duration of effect after treatment will entirely depend on factors like age, treatment, correction undertaken and the accuracy of placement by the practitioner performing the operation. It is recommended by the manufacturers to have two treatments per year and one treatment is always projected to last for 6-9 months. Some of the common side effects that have been found to occur include swelling, redness, discolouration and tenderness at the area implanted. Recovery is immediate in most of the cases.